Xiao-jing Cheng

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

ICG-r15 predicts esophageal varices in compensated liver cirrhosis: a noninvasive approach.

ICG-r15 predicts esophageal varices in compensated liver cirrhosis: a noninvasive approach.

Journal: BMC gastroenterology

Published: October 08, 2023

Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.

Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.

Journal: World journal of gastroenterology

Published: June 04, 2023

Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.

Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.

Journal: Cancer communications (London, England)

Published: May 20, 2020

The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis.

The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis.

Journal: Cancer management and research

Published: January 16, 2019

Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer.

Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer.

Journal: Cancer management and research

Published: November 23, 2018

ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.

ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.

Journal: Cell death & disease

Published: August 08, 2018

MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.

MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: February 01, 2017

Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.

Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.

Journal: Oncology reports

Published: November 21, 2015

Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer.

Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: October 27, 2015

Increased expression of S100A6 promotes cell proliferation in gastric cancer cells.

Increased expression of S100A6 promotes cell proliferation in gastric cancer cells.

Journal: Oncology letters

Published: July 03, 2015

High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

Journal: American journal of cancer research

Published: November 10, 2014

High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

Journal: American journal of cancer research

Published: October 28, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026